Detalhe da pesquisa
1.
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
N Engl J Med
; 378(20): 1908-1919, 2018 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768139
2.
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.
Clin Exp Rheumatol
; 36(4): 668-675, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29533755
3.
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
Ann Rheum Dis
; 76(1): 173-178, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27269295
4.
Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.
Rheumatology (Oxford)
; 56(9): 1484-1491, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482054